In this episode of the Convo AI World Podcast, Hermes Frangoudis interviews Emilia Molimpakis, CEO and Co-founder of thymia, who discusses how biomarker-enriched voice intelligence is becoming critical safety infrastructure for communications platforms. Emilia explains how thymia goes beyond words to understand human state in real time—analyzing not just what people say, but how they say it. By combining objective vocal biomarkers with platform policy, thymia enables voice systems to recognize risk and respond appropriately as conversations unfold.

Check out video episodes and subscribe to the Convo AI Newsletter at convoai.world